FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 154 filers reported holding FIBROGEN INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,712,357 | -81.7% | 1,374,947 | +26.3% | 0.00% | -84.0% |
Q1 2023 | $20,316,411 | +256161.5% | 1,088,768 | +120.0% | 0.02% | +127.3% |
Q4 2022 | $7,928 | -99.8% | 494,853 | +35.9% | 0.01% | +57.1% |
Q3 2022 | $4,739,000 | +44.9% | 364,221 | +17.6% | 0.01% | +40.0% |
Q2 2022 | $3,271,000 | +29.2% | 309,725 | +47.0% | 0.01% | +66.7% |
Q1 2022 | $2,532,000 | -14.7% | 210,643 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,970,000 | +191.2% | 210,643 | +111.1% | 0.00% | +200.0% |
Q3 2021 | $1,020,000 | – | 99,792 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Consulting Group Inc | 605,713 | $7,880,000 | 4.60% |
ARMISTICE CAPITAL, LLC | 4,456,000 | $57,973,000 | 1.01% |
Intercontinental Wealth Advisors, LLC | 191,300 | $2,489,000 | 0.78% |
BHK Investment Advisors, LLC | 87,450 | $1,138,000 | 0.57% |
Soleus Capital Management, L.P. | 234,026 | $3,045,000 | 0.41% |
Tri Locum Partners LP | 74,348 | $967,000 | 0.26% |
Point72 Asset Management, L.P. | 4,777,700 | $62,158,000 | 0.25% |
PRIMECAP MANAGEMENT CO/CA/ | 13,179,897 | $171,470,000 | 0.17% |
Newbridge Financial Services Group, Inc. | 20,285 | $264,000 | 0.16% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,430,526 | $18,611,000 | 0.15% |